Exact Sciences (EXAS) Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45

Go back to Exact Sciences (EXAS) Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45
Exact Sciences Corp (NASDAQ: EXAS) Delayed: 104.91 --0 (-0%)
Previous Close $104.91    52 Week High $22.80 
Open $104.91    52 Week Low $4.67 
Day High $104.91    P/E N/A 
Day Low $104.91    EPS $-0.69 
Volume 400